Selective targeting of activating and inhibitory Smads by distinct WWP2 ubiquitin ligase isoforms differentially modulates TGFβ signalling and EMT.
Ubiquitin-dependent mechanisms have emerged as essential regulatory elements controlling cellular levels of Smads and TGFβ-dependent biological outputs such as epithelial-mesenchymal transition (EMT). In this study, we identify a HECT E3 ubiquitin ligase known as WWP2 (Full-length WWP2-FL), together with two WWP2 isoforms (N-terminal, WWP2-N; C-terminal WWP2-C), as novel Smad-binding partners. We show that WWP2-FL interacts exclusively with Smad2, Smad3 and Smad7 in the TGFβ pathway. Interestingly, the WWP2-N isoform interacts with Smad2 and Smad3, whereas WWP2-C interacts only with Smad7. In addition, WWP2-FL and WWP2-C have a preference for Smad7 based on protein turnover and ubiquitination studies. Unexpectedly, we also find that WWP2-N, which lacks the HECT ubiquitin ligase domain, can also interact with WWP2-FL in a TGFβ-regulated manner and activate endogenous WWP2 ubiquitin ligase activity causing degradation of unstimulated Smad2 and Smad3. Consistent with our protein interaction data, overexpression and knockdown approaches reveal that WWP2 isoforms differentially modulate TGFβ-dependent transcription and EMT. Finally, we show that selective disruption of WWP2 interactions with inhibitory Smad7 can stabilise Smad7 protein levels and prevent TGFβ-induced EMT. Collectively, our data suggest that WWP2-N can stimulate WWP2-FL leading to increased activity against unstimulated Smad2 and Smad3, and that Smad7 is a preferred substrate for WWP2-FL and WWP2-C following prolonged TGFβ stimulation. Significantly, this is the first report of an interdependent biological role for distinct HECT E3 ubiquitin ligase isoforms, and highlights an entirely novel regulatory paradigm that selectively limits the level of inhibitory and activating Smads.
School of Biological Sciences, University of East Anglia, Norwich, UK.
S M
SM
Soond
A
A
Chantry
D000818:Animals; D015153:Blotting, Western; D019556:COS Cells; D045744:Cell Line, Tumor; D002522:Chlorocebus aethiops; D058750:Epithelial-Mesenchymal Transition / Q000187:drug effects*; D057809:HEK293 Cells; D006801:Humans; D007527:Isoenzymes / Q000235:genetics / Q000378:metabolism; D011485:Protein Binding; D034622:RNA Interference; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015398:Signal Transduction; D051785:Smad Proteins / Q000235:genetics / Q000378:metabolism*; D051899:Smad2 Protein / Q000235:genetics / Q000378:metabolism; D051900:Smad3 Protein / Q000235:genetics / Q000378:metabolism; D051906:Smad7 Protein / Q000235:genetics / Q000378:metabolism; D014158:Transcription, Genetic / Q000187:drug effects; D016212:Transforming Growth Factor beta / Q000494:pharmacology*; D044767:Ubiquitin-Protein Ligases / Q000235:genetics / Q000378:metabolism*; D054875:Ubiquitination / Q000187:drug effects
D007527:Isoenzymes; D051785:Smad Proteins; D051899:Smad2 Protein; D051900:Smad3 Protein; D051906:Smad7 Protein; D016212:Transforming Growth Factor beta; C465283:WWP2 protein, human; D044767:Ubiquitin-Protein Ligases
EMBO Rep. 2009 May;10(5):501-7
19343052
PLoS One. 2008 Jan 23;3(1):e1487
18213395
Biochim Biophys Acta. 2009 Jan;1792(1):14-26
18992329
Oncogene. 2005 Dec 1;24(54):8080-4
16027725
Nat Cell Biol. 2001 Jun;3(6):587-95
11389444
Am J Physiol Renal Physiol. 2008 May;294(5):F1157-65
18322022
Biochem Biophys Res Commun. 2002 Jan 11;290(1):431-7
11779188
EMBO J. 2008 Feb 6;27(3):482-98
18256699
Am J Physiol Renal Physiol. 2002 Sep;283(3):F431-6
12167593
Mol Biol Cell. 2005 Apr;16(4):1987-2002
15689496
Science. 1999 Feb 26;283(5406):1325-8
10037602
Cell Differ Dev. 1990 May;30(2):109-16
2201423
Mol Cell. 2000 Dec;6(6):1365-75
11163210
Cancer Res. 2007 Mar 1;67(5):2317-24
17332363
Cell Res. 2009 May;19(5):561-73
19274063
Cell Cycle. 2006 Dec;5(23):2787-95
17172861
Mol Cell Biol. 2005 Sep;25(18):8108-25
16135802
J Biol Chem. 1997 Jun 6;272(23):14611-6
9169421
Mol Cell Biol. 2007 Aug;27(15):5296-305
17526739
Curr Opin Cell Biol. 2009 Apr;21(2):166-76
19237272
J Biol Chem. 2004 May 28;279(22):23495-503
15047715
Cell Res. 2009 Jan;19(1):21-35
19030025
Cancer Res. 2007 Oct 1;67(19):9577-83
17909069
Cell. 2007 Aug 24;130(4):651-62
17719543
Cancer Res. 2001 May 15;61(10):4222-8
11358848
Blood. 2008 Nov 15;112(10):4268-75
18776082
Cell Res. 2009 Feb;19(2):156-72
19153598
Cell Death Differ. 2006 Jun;13(6):962-72
16601753
ACS Chem Biol. 2008 Oct 17;3(10):609-17
18817380
Nature. 1999 Aug 12;400(6745):687-93
10458166
Nature. 2010 Jan 28;463(7280):457-63
20110989
Nature. 1997 Jul 3;388(6637):82-7
9214507
Oncogene. 2005 Aug 29;24(37):5764-74
16123809
Cancer Cell. 2008 Jul 8;14(1):10-21
18598940